menu ☰
menu ˟

Incobotulinumtoxin A trial meets endpoints, improves muscle tone, function after stroke

17 Aug 2015
Merz Neurosciences announced that data from its phase 3 NT 201 clinical trial for incobotulinumtoxin A will be published in the medical journal Muscle & Nerve.The Post-stroke Spasticity Upper Limb Study to Investigate Efficacy and Safety (PURE) o...

Click here to view the full article which appeared in Orthotics Prosthetics

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.